PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Go Deep

BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. Score & Ratio Trend

DateScoreP/EP/BD/EPrice
Oct 2026 21,641 -3.9 1.29 0.00 340.47

BriaCell Therapeutics Corp. Quarterly Results

Line Item Apr 2026Jan 2026Oct 2025Apr 2025
Revenue 0.0 0.0 0.0 0.0
Net Profit -7,164,507.0 -7,221,820.0 -8,197,565.0 -6,126,902.0
EPS -1.0 -2.6 -4.3 -16.4

BriaCell Therapeutics Corp. Revenue & Profit: Last 3 Years

Line Item Jul 2024Jul 2023Jul 2022
Revenue 0.0 0.0 0.0
Net Profit -4,791,466.0 -20,302,394.0 -26,838,903.0
EPS -43.7 -195.0 -259.5

BriaCell Therapeutics Corp. Balance Sheet

Line Item Jul 2024Jul 2023Jul 2022
Total Assets 5,872,261.0 27,163,577.0 42,577,041.0
Total Liabilities 8,557,193.0 30,940,758.0 32,248,109.0
Total Equity -2,382,410.0 -3,777,181.0 10,328,932.0

BriaCell Therapeutics Corp. Assets & Liabilities Breakdown (USD millions)

What it owns — Jul 2024

Cash & short-term investments 14.7%Receivables 23.3%Fixed assets (tangible) 6.6%Intangible assets 3.4%Long-term investments 7.1%Other assets 44.9%

How it's funded — Jul 2024

Payables 83.8%Other liabilities 16.2%
Line Item Jul 2024Jul 2023Jul 2022
Assets
Cash & short-term investments0.921.341.0
Receivables1.40.70.0
Inventory0.00.00.0
Fixed assets (tangible)0.40.00.0
Intangible assets0.20.20.2
Long-term investments0.40.00.0
Other assets2.65.01.3
Liabilities & equity
Short-term debt0.00.00.0
Long-term debt0.00.00.0
Payables7.21.10.5
Other liabilities1.429.831.8
Shareholders' equity-2.7-3.810.3
Net tangible assets-2.6-4.010.1

BriaCell Therapeutics Corp. Cash Flow

Line Item Jul 2024Jul 2023Jul 2022
Operating Activities -24,126,128.0 -23,744,860.0 -12,484,376.0
Investing Activities -681,801.0 0.0 —
Financing Activities 4,418,926.0 3,954,300.0 -3,742,657.0

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.